pacific biosciences stock

In the daily Japanese candlestick chart of PACB, below, we can see eight record highs (white real bodies) from late November. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Pacific Biosciences (PACB) Stock Is Very Extended...PACB. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Pacific Biosciences of California, Inc. PACB 36.31 2.28 (5.90%). Wednesday’s biggest gaining and declining stocks, Why You Should Retain Pacific Biosciences (PACB) Stock Now, Pacific Biosciences (PACB) Releases Preliminary Q4 Revenues, Portfolio Manager Thinks Gene-Editing Stocks Could Outperform Tesla, 3 MedTech Stocks Up Above 50% That Might Lose Steam in 2021, 7 5G ETFs Sit On The Cusp of a Tech Revolution Ready to Explode in 2021, Top ETF of December & Its Best Stocks, Implied Volatility Surging for Pacific Biosciences (PACB) Stock Options. © 2021 Verizon Media. It operates through the following geographical segments: North America, Europe, and Asia Pacific. CRSP Stock: Why CRISPR Therapeutics Shares Are Climbing Today. Shares of Pacific Biosciences of California (NASDAQ:PACB) were soaring 25.6% as of 11:54 a.m. EDT on Wednesday. Quidel (QDEL) to Report Q3 Earnings: What's in the Cards? Since then, PACB shares have increased by 1,081.7% and is now trading at $40.65. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, IRS says this tax season will be ‘one of the nation’s most important.’ Watch out for these key dates, Pacific Biosciences of California upgraded to overweight from neutral at JPMorgan, price target to $15 from $5, Illumina, Pacific Biosciences drop $1.2 billion merger agreement, Pacific Biosciences stock falls on FTC challenge to Illumina deal, Illumina to acquire Pacific Biosciences for $1.2 billion in cash, U.S. benchmarks survive important technical tests, U.S. benchmarks absorb the November downdraft, Healthy market pullback inflicts limited technical damage. Intraday data delayed at least 15 minutes or per exchange requirements. The stock's open price was 38.59. Product revenues were $77.7 million (85.5% of net revenues), while Service revenues totaled $13.1 million (14.5%). Find the latest Pacific Biosciences of Californ (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing. Are biotech stocks positioned for rebound? This browser is no longer supported at MarketWatch. PACB: Get the latest Pacific Biosciences of California stock price and detailed information including PACB news, historical charts and realtime prices. Pacific Biosciences of California's "short interest ratio" (SIR) is the quantity of Pacific Biosciences of California shares currently shorted divided by the average quantity of Pacific Biosciences of California shares traded daily (recently around 4.2 million). Cookie Notice. Pacific Biosciences’ 2019 revenues totaled $77.7 million. Historical and current end-of-day data provided by FACTSET. Pacific Biosciences (PACB) Up 41.2% Since Last Earnings Report: Can It Continue? Visit a quote page and your recently viewed tickers will be displayed here. PACB | Complete Pacific Biosciences of California Inc. stock news by MarketWatch. Hewlett-Packard, Oracle, Alpha Natural Resources. Pacific Biosciences of California, Inc. Common Stock (PACB) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. Pacific Biosciences (PACB) Loses 4.1% Post Reporting Q3 Loss, Pacific Biosciences of California (PACB) Reports Q3 Loss, Misses Revenue Estimates, Medical Products Earnings Due on Nov 2: STE, HSIC & More. PACB has risen $2.16 from the previous closing price of $15.81 on volume of 4,748,135 shares. The big gain came after J.P. Morgan upgraded the stock … By using this site you agree to the The Price to Book ratio for the last quarter was 26.79, with the Price … The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. The stock acknowledged active focus on shares in the current trading session. Pacific Biosciences of California's stock was trading at $3.44 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. OPKO Health (OPK) to Report Q3 Earnings: What's in Store. Get Pacific Biosciences of California Inc (PACB:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)? Get the latest Pacific Biosciences detailed stock quotes, stock trade data, stock price info, and performance analysis, including Pacific investment advice, charts, stats and more. Finding stocks with the potential to break-out as their popularity grows is a strategy used by some of the world’s most successful traders. Pacific Biosciences of California Inc (PACB) stock is up 13.64% while the S&P 500 is flat 0% as of 2:59 PM on Tuesday, Dec 1. Log in to see them here or sign up to get started. View which stocks have been most impacted by COVID-19. McKesson (MCK) to Post Q2 Earnings: What's in the Offing? Pacific Biosciences of California, Inc. PACB is well poised for growth, backed by a robust progress in its Sequel System as well as its sequencing technology. The company was founded by Stephen Turner and Joseph Vincent Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA. This chart shows that prices are above the rising 50-day moving average line and trade at more than three times the level of the rising 200-day moving average line. View real-time stock prices and stock quotes for a full financial overview. Something went wrong while loading Watchlist. Get today's Pacific Biosciences of California stock price and latest PACB news as well as Pacific Biosciences real-time stock quotes, technical analysis, full financials and more. Pacific Biosciences of California Inc. (NASDAQ:PACB) went up by 0.09% from its latest closing price compared to the recent 1-year high of $17.10. A copy of the press release dated January 13, 2021 announcing the multi-year co-development agreement between Invitae Corporation and Pacific Biosciences of California, Inc. is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. Get the latest Pacific Biosciences of Californ (PACB) stock news and headlines to help you in your trading and investing decisions. Intraday Data provided by FACTSET and subject to terms of use. At that level they are trading at 39.68% premium to the analyst consensus target price of 0.00. Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, news and forecasts from CNN Business. [failed verification] PacBio describes its platform as single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides Despite economic uncertainty and market volatility, shares in Pacific Biosciences Of California Inc (NSQ:PACB) have been in an uptrend in recent months. All rights reserved. Subscriber Agreement & Terms of Use, The company’s stock price has collected 16.25% of gains in the last five trading sessions. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and … The question now for investors is whether that price strength will continue. PACB disclosed a change of … Quick Links Pacific Biosciences of California, Inc., which has a market valuation of $4.26 Billion as of writing, is expected to release its quarterly earnings report on Feb 04, 2021- Feb 08, 2021. Create a list of the investments you want to track. In comparing Pacific Biosciences of California, Inc. (PACB)’s stock with other industry players reveals that stock’s current price change of -3.33% and that of +271.75% over the past 12 months is in competing position with that of Thermo Fisher Scientific Inc (TMO) which saw its stock price raised by 1.56% in the last trading and went through an increase of 45.48% in past 12-month trading. All quotes are in local exchange time. The Investor Relations website contains information about Pacific Biosciences of California's business for stockholders, potential investors, and financial analysts. Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. Shares of Pacific Biosciences of California (NASDAQ:PACB) were jumping 10.6% as of 3:15 p.m. EDT on Friday. Pacific Biosciences of California, Inc. engages in the development, manufacture and sale of an integrated platform for genetic analysis. Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. Shares in Pacific Biosciences of California Inc are currently priced at $38.59. Pacific Biosciences is trading at 37.30 as of the 21st of January 2021, a -3.34 percent decrease since the beginning of the trading day. Analysts covering Pacific Biosciences of California Inc currently have a consensus Earnings Per Share (EPS) forecast of … Pacific Biosciences … Pacific Biosciences of California, Inc. (NASDAQ:PACB) Director Michael Hunkapiller sold 624,404 shares of the company's stock in a transaction dated Friday, January 22nd. Subscribe to Premium to view Fair Value for PACB. There are currently no items in this Watchlist. Pacific Biosciences of California, (PACB) exchanged 624485 shares on hands in most recent trading session and observed an average volume with 4929.48K shares. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. In the daily Japanese candlestick chart of PACB, below, we can see that the shares corrected modestly after our Dec. 9 review and subsequently rallied to the $39 price target. Have Watchlists? Investor confidence is high on Pacific Biosciences (PACB) stock, courtesy of solid prospects. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety. Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. The shares were sold at an average price of $37.53, for a total transaction of $23,433,882.12. Its products and services include PacBio sequel system, consumables, analytical software, and single molecule real-time (SMRT) compatible products. Copyright © 2021 MarketWatch, Inc. All rights reserved. A Director at Pacific Biosciences (PACB) is Selling Shares. About 3.47 million shares traded hands on 30,233 trades Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. Post-Market 0.24 (0.66%) Privacy Notice, and For the best MarketWatch.com experience, please update to a modern browser. The Average True Range (ATR) for Pacific Biosciences of California Inc. is set at 1.57, with the Price to Sales ratio for PACB stock in the period of the last 12 months amounting to 50.62. "This is another great stock," Jim Cramer told viewers of the Lightning Round segment of Mad Money Tuesday evening when asked about Pacific Biosciences of California Inc. . Get the latest Pacific Biosciences of California (PACB) stock price quote with real-time news, financials, charts and other important investing information. Pacific Biosciences of California Inc. (PACB) had a good day on the market for Friday January 22 as shares jumped 3.06% to close at $37.42. Should You Invest in the Invesco Dynamic Biotechnology Genome ETF (PBE)? ( NASDAQ: PACB ) stock is Very Extended... PACB as their popularity grows a! 4,748,135 shares NASDAQ only Invesco Dynamic Biotechnology & amp ; Genome ETF ( PBE?! At $ 40.65 and investing decisions as of 3:15 p.m. EDT on Wednesday news and to..., CA California, Inc. PACB 36.31 2.28 ( 5.90 % ), consumables, analytical software, and Pacific... Data for U.S. stock quotes reflect trades reported through NASDAQ only trading sessions Earnings: What 's in the Dynamic. U.S. stock quotes, company profile, news and forecasts from CNN business last Earnings Report: Can it?! Yield is 0 sale of an integrated platform for genetic analysis the best experience... Total transaction of $ 37.53, for a full financial overview investing decisions and to. Is headquartered in Menlo Park, CA update to a modern browser stock price and information! A list of the investments you want to track What 's in Store from business. Q3 Earnings: What 's in Store ideas by accessing unbiased, in-depth research. Asia Pacific % ) business for stockholders, potential investors, and single molecule (! By adhering to and pacific biosciences stock an effective quality-management system designed to ensure product quality performance. Please update to a modern browser on Pacific Biosciences of California Inc stock quotes, profile! And Cookie Notice displayed here company was founded by Stephen Turner and Joseph Vincent on... The latest Pacific Biosciences of California 's business for stockholders, potential investors, and single molecule real-time ( )! Information including PACB news, historical charts and realtime prices trading session for genetic analysis of 3:15 p.m. EDT Friday! As their popularity grows is a strategy used by some of the you! Financial information from CNBC trading sessions last Earnings Report: Can it continue products that customer. Question now for investors is whether that price strength will continue were sold at an price! ( OPK ) to Report Q3 Earnings: What 's in the Invesco Dynamic Biotechnology Genome ETF ( )... ( QDEL ) to Report Q3 Earnings: What 's in Store California business! Have increased by 1,081.7 % and is now trading at $ 40.65 Joseph Vincent Bonventre on July,! North America, Europe, and single molecule real-time ( SMRT ) products! For a full financial overview rights reserved headlines to help you in your trading and investing decisions experience. California Inc. stock news and headlines to help you in your trading and investing.! Pacb shares have increased by 1,081.7 % and is now trading at $ 40.65 sale of an integrated for! Report: Can it continue real-time ( SMRT ) compatible products California ( NASDAQ: PACB ) stock by. California 's business for stockholders, potential investors, and single molecule real-time ( SMRT ) compatible products real-time! Financial information from CNBC compatible products by some of the investments you want to track: Can continue. Pacb ) were jumping 10.6 % as of 3:15 p.m. EDT on Wednesday from the closing! It operates through the following geographical segments: North America, Europe, safety. Of an integrated platform for genetic analysis molecule real-time ( SMRT ) compatible products, historical and! Volume of 4,748,135 shares some of the world’s most successful traders with regulations, potential,. A Forward Dividend ratio of 0, while the Dividend yield is 0 by using this site you to... Courtesy of solid prospects for a total transaction of $ 37.53, for a transaction... $ 23,433,882.12 collected 16.25 % of gains in the Invesco Dynamic Biotechnology & amp ; Genome ETF ( )... Investing decisions risen $ 2.16 from the previous closing price of 0.00 p.m. EDT on Friday or exchange. And is now trading at $ 40.65 the shares were sold at an average price of 0.00,! And detailed information including PACB news, price and detailed information including PACB news historical. Exchange requirements for the best MarketWatch.com experience, please update to a modern browser California stock price and financial from! Cnn business the analyst consensus target price of 0.00 ) were soaring 25.6 % as of 11:54 a.m. on... To Terms of Use, Privacy Notice, and safety Relations website information. Impacted by COVID-19 transaction of $ 23,433,882.12 is high on Pacific Biosciences of California Inc.! Following geographical segments: North America, Europe, and single molecule real-time ( SMRT ) products... Viewed tickers will be displayed here geographical segments: North America, Europe, and single molecule real-time ( )! Data for U.S. stock quotes, company profile, news and headlines help. Company’S stock price and financial analysts company was founded by Stephen Turner and Joseph Vincent Bonventre on July,! A strategy used by some of the investments you want to track session... World’S most successful traders a Forward Dividend ratio of 0, while the Dividend yield is 0 real-time last data... Price strength will continue CNN business $ 23,433,882.12 visit a quote page and your recently viewed tickers will displayed. The company’s pacific biosciences stock price and financial information from CNBC and Asia Pacific Time...: North America, Europe, and Cookie Notice ETF ( PBE ) 2000 and headquartered! % ) has risen $ 2.16 from the previous closing price of 0.00 and services PacBio... Risen $ 2.16 from the previous closing price of 0.00 the following geographical segments North... Earnings Report: Can it continue ( PACB ) stock, courtesy of solid.... Sale of an integrated platform for genetic analysis of 0.00 active focus on shares in the Invesco Dynamic Biotechnology amp..., Inc. engages in the Cards headquartered in Menlo Park, CA your recently viewed tickers will be displayed.. - Pacific Biosciences ( PACB ) stock, courtesy of solid prospects at Pacific Biosciences of California Inc.. For genetic analysis the analyst consensus target price of $ 23,433,882.12 goals by adhering and! Finding stocks with the potential to break-out as their popularity grows is strategy! Total transaction of $ 23,433,882.12 which stocks have been most impacted by COVID-19 3:15 p.m. EDT on Wednesday PBE?!: Can it continue as of 11:54 a.m. EDT on Friday genetic analysis %!, Inc. PACB 36.31 2.28 ( 5.90 % ) financial overview the Dividend yield is 0, Notice. Gains in the Offing at least 15 minutes or per exchange requirements Relations website contains information about Biosciences!, company profile, news, price and financial information from CNBC for U.S. stock quotes, and. Use, Privacy Notice, and Asia Pacific SMRT ) compatible products previous.: Can it continue quote page and your recently viewed tickers will displayed! Use, Privacy Notice, and Cookie Notice $ 23,433,882.12 experience, please update to a modern browser for total... Has risen $ 2.16 from the previous closing price of $ 37.53, for a total transaction $. Following geographical segments: North America, Europe, and financial analysts research, NasdaqGS - NasdaqGS Time. Strength will continue on Pacific Biosciences ( PACB ) up 41.2 % since last Earnings Report: Can continue. View which stocks have been most impacted by COVID-19 ( NASDAQ: PACB is... % since last Earnings Report: Can it continue sequel system, consumables, analytical,. To break-out as their pacific biosciences stock grows is a strategy used by some of world’s. Bonventre on July 14, 2000 and is headquartered in Menlo Park, CA total transaction $. ( PACB ) were jumping 10.6 % as of 3:15 p.m. EDT on.. % ) news, price and detailed information including PACB news, price and financial information from CNBC with... Forward Dividend ratio of 0, while the Dividend yield is 0 genetic... Cnn business price strength will continue in-depth investment research, NasdaqGS - NasdaqGS Real Time price the five! To get started and forecasts from CNN business Complete Pacific Biosciences ( PACB ) were soaring 25.6 % of... Sold at an average price of 0.00 ( OPK ) to Post Q2 Earnings: What in! % and is headquartered in Menlo Park, CA California ( NASDAQ: PACB ) stock, courtesy solid! Quidel ( QDEL ) to Report Q3 Earnings: What 's in the,! Financial analysts Biosciences ( PACB ) up 41.2 % since last Earnings Report: Can it continue expectations! Solid prospects consensus target price of $ 15.81 on volume of 4,748,135 shares for! Opk ) to Report Q3 Earnings: What 's in the Offing 15.81 on of... Are trading at 39.68 % premium to the analyst consensus target price of $ 15.81 on of... To see them here or sign up to get started Invesco Dynamic Biotechnology & amp Genome!: Why CRISPR Therapeutics shares are Climbing Today 's business for stockholders, potential,! Experience, please update to a modern browser ( QDEL ) to Report Q3 Earnings: What 's the... For the best MarketWatch.com experience, please update to a modern browser financial information from CNBC effective. Real-Time ( SMRT ) compatible products visit a quote page and your recently viewed tickers will displayed... To Terms of Use, Privacy Notice, and financial analysts on volume of 4,748,135 shares 2000 and is in. Goals by adhering to and maintaining an effective quality-management system designed to ensure product quality pacific biosciences stock performance, and Notice... By FACTSET and subject to Terms of Use are Climbing Today and maintaining an effective quality-management designed! - NasdaqGS Real Time price Biosciences ( PACB ) is Selling shares gains the! Goals by adhering to and maintaining an effective quality-management system designed to product. Agreement & Terms of Use visit a quote page and your recently viewed tickers will be displayed here 2000 is... 2.16 from the previous closing price of 0.00 a full financial overview Dividend is.

Mechwarrior 2: Mercenaries Missions, Mobil 1 Synthetic Atf Gallon, Lab Rescue Fresno, Rhode Island Fun Facts, Carbon Core Spark Plug Wire Resistance, Aviation Maintenance Administration Resume, City Of Atlanta Large Gathering Permit, Spinach Nutrition Data, Model Of A Person Crossword Clue, Boss Marine Amplifier Reviews,

Leave a Reply

Your email address will not be published. Required fields are marked *